FDA
-
-
-
-
-
-
-
MetaVia Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH
322,878 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

